Life without white fat: a transgenic mouse.

We have generated a transgenic mouse with no white fat tissue throughout life. These mice express a dominant-negative protein, termed A-ZIP/F, under the control of the adipose-specific aP2 enhancer/promoter. This protein prevents the DNA binding of B-ZIP transcription factors of both the C/EBP and Jun families. The transgenic mice (named A-ZIP/F-1) have no white adipose tissue and dramatically reduced amounts of brown adipose tissue, which is inactive. They are initially growth delayed, but by week 12, surpass their littermates in weight. The mice eat, drink, and urinate copiously, have decreased fecundity, premature death, and frequently die after anesthesia. The physiological consequences of having no white fat tissue are profound. The liver is engorged with lipid, and the internal organs are enlarged. The mice are diabetic, with reduced leptin (20-fold) and elevated serum glucose (3-fold), insulin (50- to 400-fold), free fatty acids (2-fold), and triglycerides (3- to 5-fold). The A-ZIP/F-1 phenotype suggests a mouse model for the human disease lipoatrophic diabetes (Seip-Berardinelli syndrome), indicating that the lack of fat can cause diabetes. The myriad of consequences of having no fat throughout development can be addressed with this model.

[1]  D. Bernlohr,et al.  Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. S. Kim,et al.  Mechanism of specificity in the Fos-Jun oncoprotein heterodimer , 1992, Cell.

[3]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[4]  R. Palmiter,et al.  Regulation of fat and muscle development by transforming growth factor alpha in transgenic mice and in cultured cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  C. Vinson,et al.  A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Thomas,et al.  Weighing the Options , 1995 .

[7]  S. McKnight,et al.  Isolation of a recombinant copy of the gene encoding C/EBP. , 1988, Genes & development.

[8]  T. Hashimoto,et al.  Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid beta-oxidation system. , 1994, Biochemical and biophysical research communications.

[9]  J. Flatt,et al.  Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. , 1985, International journal of obesity.

[10]  J. Gimble,et al.  CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.

[11]  Bruce M. Spiegelman,et al.  Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos , 1987, Cell.

[12]  B. Spiegelman,et al.  Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. , 1993, Genes & development.

[13]  R. Stone.  Harrison's Principles of Internal Medicine , 1991 .

[14]  T. W. James,et al.  Assay for nanogram quantities of DNA in cellular homogenates. , 1979, Analytical biochemistry.

[15]  T. Roderick,et al.  FVB/N: an inbred mouse strain preferable for transgenic analyses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Spiegelman,et al.  Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. , 1995, The Journal of clinical investigation.

[17]  J. Flier.  Leptin expression and action: new experimental paradigms. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Doering,et al.  Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. , 1985, Biochemical and biophysical research communications.

[19]  J. Ntambi,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. , 1989, Genes & development.

[20]  L. Kozak,et al.  Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. , 1991, Genes & development.

[21]  K. Chada,et al.  Mini-mouse: phenotypic characterization of a transgenic insertional mutant allelic to pygmy. , 1994, Genetical research.

[22]  A. Stenbit,et al.  Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 , 1995, Nature.

[23]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[24]  F. Villarroya,et al.  CCAAT/enhancer binding proteins alpha and beta are transcriptional activators of the brown fat uncoupling protein gene promoter. , 1994, Biochemical and Biophysical Research Communications - BBRC.

[25]  D. Ricquier.  [Brown adipose tissue]. , 1989, La Revue du praticien.

[26]  R. Burcelin,et al.  Acute stimulation of glucose metabolism in mice by leptin treatment , 1997, Nature.

[27]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[28]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[29]  D. Ginty,et al.  A Dominant-Negative Inhibitor of CREB Reveals that It Is a General Mediator of Stimulus-Dependent Transcription of c-fos , 1998, Molecular and Cellular Biology.

[30]  M. Reitman,et al.  An enhancer/locus control region is not sufficient to open chromatin , 1993, Molecular and cellular biology.

[31]  S. Freytag,et al.  Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. , 1994, Genes & development.

[32]  D. Allison,et al.  The search for human obesity genes. , 1998, Science.

[33]  N. Barzilai,et al.  Short Term Effects of Leptin on Hepatic Gluconeogenesis and in Vivo Insulin Action* , 1997, The Journal of Biological Chemistry.

[34]  M. Reitman,et al.  GENOMIC ORGANIZATION, PROMOTER ACTIVITY, AND ACTIVATION BY CCAAT/ENHANCER-BINDING PROTEIN a* , 1995 .

[35]  R. Stollberger,et al.  Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. , 1995, The Journal of clinical investigation.

[36]  C. Vinson,et al.  Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. , 1993, Genes & development.

[37]  H. Fukuda,et al.  Transcriptional regulatory region for expression of the rat ATP citrate-lyase gene. , 1997, European journal of biochemistry.

[38]  D. Cooper,et al.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance , 1998, The Lancet.

[39]  R. Jaenisch,et al.  Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? , 1989, Genes & development.

[40]  P. Smith,et al.  Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. , 1988, The Journal of biological chemistry.

[41]  T. Noguchi,et al.  Transcriptional regulatory regions for expression of the rat fatty acid synthase , 1997, FEBS letters.

[42]  M. Olive,et al.  A Dominant Negative to Activation Protein-1 (AP1) That Abolishes DNA Binding and Inhibits Oncogenesis* , 1997, The Journal of Biological Chemistry.

[43]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .

[44]  P S Kim,et al.  Preferential heterodimer formation by isolated leucine zippers from fos and jun. , 1989, Science.

[45]  O. Trygstad,et al.  Generalized lipodystrophy, congenital and acquired (lipoatrophy) , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[46]  F. Villarroya,et al.  CCAAT/enhancer binding proteins α and β are transcriptional activators of the brown fat uncoupling protein gene promoter , 1994 .

[47]  B. Spiegelman,et al.  Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity. , 1997, Molecular endocrinology.

[48]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[49]  J. Weissenbach,et al.  Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Spiegelman,et al.  Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. , 1983, The Journal of biological chemistry.

[51]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[52]  J. Peters,et al.  Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)* , 1998, The Journal of Biological Chemistry.

[53]  C N Boozer,et al.  Dietary obesity in nine inbred mouse strains. , 1992, The American journal of physiology.

[54]  M. Lane,et al.  CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Nicholls,et al.  Thermogenic mechanisms in brown fat. , 1984, Physiological reviews.

[56]  R. Idzerda,et al.  Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A , 1996, Nature.

[57]  J. Kopecký,et al.  Uncoupling protein in embryonic brown adipose tissue--existence of nonthermogenic and thermogenic mitochondria. , 1988, Biochimica et biophysica acta.

[58]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[59]  Z. Wu,et al.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.

[60]  M. Quon,et al.  The Mouse obese Gene , 1995, The Journal of Biological Chemistry.

[61]  S. Mandrup,et al.  Regulating Adipogenesis* , 1997, The Journal of Biological Chemistry.

[62]  A. Bradley,et al.  Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.

[63]  M. Reitman,et al.  Hyperleptinemia of Pregnancy Associated with the Appearance of a Circulating Form of the Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[64]  F. Chehab,et al.  Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin , 1996, Nature Genetics.

[65]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[66]  J. Peters,et al.  Environmental contributions to the obesity epidemic. , 1998, Science.

[67]  M. Reitman,et al.  Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. , 1998, Endocrinology.

[68]  J. Stephens,et al.  Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. , 1992, Journal of molecular endocrinology.

[69]  G. Lopaschuk,et al.  Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. , 1997, Metabolism: clinical and experimental.

[70]  V. Barr,et al.  Insulin stimulates both leptin secretion and production by rat white adipose tissue. , 1997, Endocrinology.

[71]  M. Glotzer,et al.  Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression. , 1985, The Journal of biological chemistry.

[72]  M. Lane,et al.  Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[73]  C. Burant,et al.  Troglitazone action is independent of adipose tissue. , 1997, The Journal of clinical investigation.

[74]  M. Olive,et al.  Extending dimerization interfaces: the bZIP basic region can form a coiled coil. , 1995, The EMBO journal.